久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Orion Biotechnology Receives Funding to Test OB-002 for COVID-19 americanpharmaceuticalreview
    August 11, 2020
    Orion Biotechnology Canada announced it is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP), to support the development of Orion’s lead compound, OB-002 ...
  • Orion Biotechnology Receives Funding to Develop OB-002 contractpharma
    July 31, 2020
    Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company, is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP) to support the development of Orion’s ...
PharmaSources Customer Service